175 related articles for article (PubMed ID: 26437542)
1. Metastatic Neuroendocrine Carcinoma of the Breast Identified by Tc-99m-HYNIC-TOC SPECT/CT: A Rare Case Report.
Claimon A; Chuthapisith S; Samarnthai N; Pusuwan P
J Med Assoc Thai; 2015 Aug; 98(8):828-32. PubMed ID: 26437542
[TBL] [Abstract][Full Text] [Related]
2. Clinical value of
Chen H; Li Y; Gao X; Shen X
Clin Imaging; 2018; 52():365-369. PubMed ID: 30248495
[TBL] [Abstract][Full Text] [Related]
3. Clinical application of
Xu J; Li Y; Xu X; Zhang J; Zhang Y; Yu X; Huang D
Ann Nucl Med; 2018 Aug; 32(7):446-452. PubMed ID: 29926342
[TBL] [Abstract][Full Text] [Related]
4. Incremental value of
Trogrlic M; Težak S
Nuklearmedizin; 2017 Jun; 56(3):97-107. PubMed ID: 28164207
[TBL] [Abstract][Full Text] [Related]
5. Synchronous metastases to the liver and pancreas from a primary neuroendocrine carcinoma of the breast diagnosed by fine-needle aspiration.
McIntire M; Siziopikou K; Patil J; Gattuso P
Diagn Cytopathol; 2008 Jan; 36(1):54-7. PubMed ID: 18064696
[TBL] [Abstract][Full Text] [Related]
6. 99mTc-HYNIC-TOC imaging in the evaluation of pancreatic masses which are potential neuroendocrine tumors.
Qiao Z; Zhang J; Jin X; Huo L; Zhu Z; Xing H; Li F
Clin Nucl Med; 2015 May; 40(5):397-400. PubMed ID: 25706799
[TBL] [Abstract][Full Text] [Related]
7. Multinodular cutaneous spread in neuroendocrine tumor of the breast : an unusual presentation.
Vidulich KA; Donley SE; Duvic M
Am J Clin Dermatol; 2007; 8(6):379-83. PubMed ID: 18039021
[TBL] [Abstract][Full Text] [Related]
8. The clinical value of scintigraphy of neuroendocrine tumors using (99m)Tc-HYNIC-TOC.
Artiko V; Sobic-Saranovic D; Pavlovic S; Petrovic M; Zuvela M; Antic A; Matic S; Odalovic S; Petrovic N; Milovanovic A; Obradovic V
J BUON; 2012; 17(3):537-42. PubMed ID: 23033296
[TBL] [Abstract][Full Text] [Related]
9. Microcystic Serous Cystadenoma Masquerading as Pancreatic Neuroendocrine Tumor on 99m Tc-HYNIC-TOC SPECT/CT.
Cai W; Dong Y; Zhao T; Dong A; Zhao Q
Clin Nucl Med; 2024 Feb; 49(2):e87-e89. PubMed ID: 38048519
[TBL] [Abstract][Full Text] [Related]
10. Breast metastasis and lung large-cell neuroendocrine carcinoma: first clinical observation.
Papa A; Rossi L; Verrico M; Di Cristofano C; Moretti V; Strudel M; Zoratto F; Minozzi M; Tomao S
Clin Respir J; 2017 Sep; 11(5):574-578. PubMed ID: 26365150
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin receptor imaging in non-(131)I-avid metastatic differentiated thyroid carcinoma for determining the feasibility of peptide receptor radionuclide therapy with (177)Lu-DOTATATE: low fraction of patients suitable for peptide receptor radionuclide therapy and evidence of chromogranin A level-positive neuroendocrine differentiation.
Jois B; Asopa R; Basu S
Clin Nucl Med; 2014 Jun; 39(6):505-10. PubMed ID: 24662668
[TBL] [Abstract][Full Text] [Related]
12. Additional lesions detected in therapeutic scans with 177Lu-DOTATATE reflect higher affinity of 177Lu-DOTATATE for somatostatin receptors.
Mirzaei S; Bastati B; Lipp RW; Knoll P; Zojer N; Ludwig H
Oncology; 2011; 80(5-6):326-9. PubMed ID: 21791941
[TBL] [Abstract][Full Text] [Related]
13. Fine needle aspiration biopsy of neuroendocrine breast carcinoma metastatic to the thyroid. A case report.
Loo CK; Burchett IJ
Acta Cytol; 2003; 47(1):83-7. PubMed ID: 12585036
[TBL] [Abstract][Full Text] [Related]
14. Breast Carcinoma With Unrecognized Neuroendocrine Differentiation Metastasizing to the Pancreas: A Potential Diagnostic Pitfall.
Christensen L; Mortensen MB; Detlefsen S
Int J Surg Pathol; 2016 Aug; 24(5):463-7. PubMed ID: 26912472
[TBL] [Abstract][Full Text] [Related]
15. Clinical indications to the use of (99m)Tc-EDDA/HYNIC-TOC to detect somatostatin receptor-positive neuroendocrine tumors.
Parisella MG; Chianelli M; D'Alessandria C; Todino V; Mikolajczak R; Papini E; Dierckx RA; Scopinaro F; Signore A
Q J Nucl Med Mol Imaging; 2012 Feb; 56(1):90-8. PubMed ID: 21068709
[TBL] [Abstract][Full Text] [Related]
16. A rare case of medullary carcinoma thyroid metastasizing to bilateral breast parenchyma.
Hassan A; Siddiqui M; Jahangir S
Nucl Med Rev Cent East Eur; 2016; 19(B):17-19. PubMed ID: 27900756
[TBL] [Abstract][Full Text] [Related]
17. [A Case of Neuroendocrine Carcinoma with Long-Term Abnormal Nipple Discharge].
Enomoto K; Sakurai K
Gan To Kagaku Ryoho; 2018 Dec; 45(13):2479-2481. PubMed ID: 30692504
[TBL] [Abstract][Full Text] [Related]
18. [Metastatic breast carcinoma with neuroendocrine differentiation--its combined therapy with tamoxifen and the somatostatin analog octreotide].
Rischke HC; Staib-Sebler E; Mose S; Adams SW; Herrmann G; Böttcher HD; Lorenz M
Dtsch Med Wochenschr; 1999 Feb; 124(7):182-6. PubMed ID: 10093577
[TBL] [Abstract][Full Text] [Related]
19. Patient-specific radiation dosimetry of 99mTc-HYNIC-Tyr3-octreotide in neuroendocrine tumors.
Grimes J; Celler A; Birkenfeld B; Shcherbinin S; Listewnik MH; Piwowarska-Bilska H; Mikolajczak R; Zorga P
J Nucl Med; 2011 Sep; 52(9):1474-81. PubMed ID: 21795364
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic role of 99mTc-dual receptor targeted probe and targeted peptide bombesin (RGD-BBN) SPET/CT in the detection of malignant and benign breast tumors and axillary lymph nodes compared to ultrasound.
Ji T; Sun Y; Chen B; Ji B; Gao S; Ma Q; Cheng G; Zhang H
Hell J Nucl Med; 2015; 18(2):108-13. PubMed ID: 26187209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
